These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 17889119

  • 1. Risk factors and prognosis for proteinuria in renal transplant recipients.
    Sancho A, Gavela E, Avila A, Morales A, Fernández-Nájera JE, Crespo JF, Pallardo LM.
    Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
    [Abstract] [Full Text] [Related]

  • 2. Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survival.
    Sancho Calabuig A, Pallardó Mateu LM, Avila Bernabeu AI, Gavela Martínez E, Beltrán Catalán S, Crespo Albiach JF.
    Transplant Proc; 2009 Sep; 41(6):2122-5. PubMed ID: 19715850
    [Abstract] [Full Text] [Related]

  • 3. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
    Ibis A, Akgül A, Ozdemir N, Colak T, Sezer S, Arat Z, Haberal M.
    Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
    [Abstract] [Full Text] [Related]

  • 4. Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction.
    Gutiérrez MJ, González E, Andrés A, Morales JM.
    Transplant Proc; 2009 Jun; 41(6):2348-50. PubMed ID: 19715916
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 6. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation.
    Fernández-Fresnedo G, Plaza JJ, Sánchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, Arias M.
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii47-51. PubMed ID: 15192136
    [Abstract] [Full Text] [Related]

  • 7. Effect of overweight on kidney transplantation outcome.
    Sancho A, Avila A, Gavela E, Beltrán S, Fernández-Nájera JE, Molina P, Crespo JF, Pallardó LM.
    Transplant Proc; 2007 Sep; 39(7):2202-4. PubMed ID: 17889137
    [Abstract] [Full Text] [Related]

  • 8. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

  • 9. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM, Gich I, Bonfill X, Solà R, Guirado L, Facundo C, Sainz Z, Puig T, Silva I, Ballarín J.
    Transplant Proc; 2009 Jul 27; 41(6):2151-5. PubMed ID: 19715859
    [Abstract] [Full Text] [Related]

  • 10. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR, Ghafari A, Hajizadeh E, Kazemnejad A.
    Exp Clin Transplant; 2010 Dec 27; 8(4):277-82. PubMed ID: 21143092
    [Abstract] [Full Text] [Related]

  • 11. Metabolic syndrome is related to long-term graft function in renal transplant recipients.
    Ozdemir FN, Karakan S, Akgul A, Haberal M.
    Transplant Proc; 2009 Sep 27; 41(7):2808-10. PubMed ID: 19765441
    [Abstract] [Full Text] [Related]

  • 12. Proteinuria after conversion to sirolimus in renal transplant recipients.
    Sahin GM, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Dec 27; 38(10):3473-5. PubMed ID: 17175308
    [Abstract] [Full Text] [Related]

  • 13. Early assessment of renal resistance index after kidney transplant can help predict long-term renal function.
    Saracino A, Santarsia G, Latorraca A, Gaudiano V.
    Nephrol Dial Transplant; 2006 Oct 27; 21(10):2916-20. PubMed ID: 16891640
    [Abstract] [Full Text] [Related]

  • 14. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA, D'Elia JA, Gleason RE, Shaffer D, Monaco AP.
    Clin Nephrol; 1995 Sep 27; 44(3):185-92. PubMed ID: 8556835
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.
    Transpl Int; 2003 May 27; 16(5):313-20. PubMed ID: 12759722
    [Abstract] [Full Text] [Related]

  • 16. IgA nephropathy in kidney allograft recipients-therapeutic perspective.
    Pazik J, Baczkowska T, Lewandowski Z, Lewandowska D, Ostrowska J, Perkowska Ptasińska A, Mróz A, Miszewska-Szyszkowska D, Rowinski W, Durlik M.
    Transplant Proc; 2006 May 27; 38(1):112-4. PubMed ID: 16504678
    [Abstract] [Full Text] [Related]

  • 17. Renal allograft protection with early angiotensin-converting enzyme inhibitors administration.
    Montanaro D, Gropuzzo M, Tulissi P, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Bresadola F, Mioni G.
    Transplant Proc; 2004 Apr 27; 36(3):692-4. PubMed ID: 15110633
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2008 Sep 27; 6(3):203-10. PubMed ID: 18954298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.